A genetically modified mouse model with IDH1 R132H mutation and PDGF overexpression was proposed, reflecting the phenotypic features of human gliomas, including 2-HG production, hypermethylation, and differential expression of a number of genes in comparison with a tumor without mutation in IDH1 [141]. This evidence concerns the gene IDH1 and central nervous system cancer.